Related Experiment Videos
[Teratogenic effect of coumarins].
Zentralblatt Fur Gynakologie
|January 1, 1987
Summary
Coumarin use in early pregnancy can lead to birth defects, known as coumarin embryopathy. This necessitates avoiding coumarins during the first trimester due to significant fetal abnormality risks.
Area of Science:
- Teratology
- Pharmacology
- Medical Genetics
Background:
- Coumarins are anticoagulant medications with known teratogenic potential.
- Early pregnancy exposure to coumarins can result in a spectrum of congenital malformations.
- Coumarin embryopathy is a recognized risk associated with anticoagulant therapy.
Observation:
- A case of coumarin embryopathy is presented following maternal administration of Falithrom in early pregnancy.
- Typical features observed include nasal bridge hypoplasia and skeletal stippled calcifications.
- Stippled epiphyses of long bones are a characteristic finding in affected neonates.
Findings:
- The study highlights the association between first-trimester coumarin exposure and specific fetal malformations.
- Reported fetal abnormality rates associated with coumarin use in early pregnancy approach 30%.
- The Conradi-Hünermann type of chondrodysplasia punctata is a recognized manifestation.
Implications:
- Absolute contraindication of coumarins during the first trimester of pregnancy is strongly recommended.
- Alternative anticoagulant therapies with better safety profiles for pregnancy should be considered.
- Awareness of these risks is crucial for managing anticoagulation in pregnant patients.